Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
Legislation Search

H.R. 11024: To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage of allergy and asthma diagnostic testing and allergen immunotherapy.

This bill would require most private health insurance plans to cover certain allergy and asthma services starting with plan years beginning on or after January 1, 2028.

What the bill would require

It would add a new federal insurance rule covering two main areas:

  • Allergy and asthma diagnostic testing
  • Allergen immunotherapy (treatments intended to reduce allergic sensitivity over time, such as allergy shots)

Coverage for allergy and asthma testing

Health plans and insurers would have to cover allergy and asthma diagnostic testing when it is done according to recognized clinical standards. The bill says insurers could not:

  • Limit how many allergens can be tested for one person, if the testing is clinically appropriate.
  • Deny payment just because the testing happened on the same day as an office visit.
  • Deny coverage because the record does not include certain types of documentation about medical decision-making or interpretation.
  • Deny coverage simply because both skin testing and blood/serum testing were ordered.
  • Apply prior authorization, step therapy, or other utilization management rules that conflict with recognized clinical standards.

Coverage for allergen immunotherapy

If a health plan covers allergen immunotherapy at all, it would have to cover it in a way that matches recognized clinical standards. The bill says coverage would need to include patient-specific extract preparation and medically necessary parts of treatment, including:

  • The buildup phase
  • Dose adjustments
  • Specific extract concentrations

The bill also says insurers could not impose certain billing or coverage limits, such as:

  • Medically unlikely edit limits
  • Volume-based reimbursement caps
  • Predetermined aliquot sizes
  • Other quantitative limits that do not match coding rules or clinical standards
  • Requirements that all treatment units be billed on a single date of service
  • Documentation, prior authorization, or other utilization controls that conflict with recognized clinical standards

Definitions in the bill

The bill defines several terms to clarify what must be covered. For example:

  • Allergy and asthma diagnostic testing includes skin testing, intradermal testing, patch testing, and spirometry.
  • Allergen immunotherapy includes a set of specific CPT-coded services used for allergy treatment.
  • Recognized clinical standards means standards that align with practice parameters published by national allergy, asthma, or immunology specialty organizations.

When it would take effect

The requirements would apply to plan years beginning on or after January 1, 2028.

Relevant Companies

None found

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

2 bill sponsors

Actions

2 actions

Date Action
Nov. 12, 2026 Introduced in House
Nov. 12, 2026 Referred to the House Committee on Energy and Commerce.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.